Shares of Nevro Corp. (NYSE:NVRO – Get Rating) have earned an average rating of “Hold” from the sixteen brokerages that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. The […]
Wall Street brokerages predict that Nevro Corp. (NYSE:NVRO – Get Rating) will report $86.06 million in sales for the current fiscal quarter, according to Zacks Investment Research. Six analysts have made estimates for Nevro’s earnings, with the highest sales estimate coming in at $86.33 million and the lowest estimate coming in at $85.90 million. Nevro […]
Nevro Corp. (NYSE:NVRO – Get Rating) General Counsel Kashif Rashid bought 1,500 shares of the stock in a transaction that occurred on Friday, March 11th. The stock was purchased at an average price of $64.04 per share, for a total transaction of $96,060.00. The transaction was disclosed in a legal filing with the Securities & […]
Swiss National Bank Purchases 500 Shares of Nevro Corp (NYSE:NVRO) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Nevro Corp, a provider of evidence-based solutions for the treatment of chronic pain, announced the settlement of its patent lawsuit with Nalu Medical.